By focusing on the BRD7-mediated assembly of the PBAF complex in CD8+ T cells, we uncovered a possible therapeutic target to interfering with the induction of functional effector CD8+ T cells, and this could open a new avenue for the treatment of various diseases including viral infections, tumors, or autoimmune diseases. This evidence concerns the gene CD8A and autoimmune disease.